Compound screening is an important part of active molecule development. With the continuous development of science and technology, high throughput screening of compounds has become the direction of development.
CD BioSciences offers bacteria-associated-compound screening service. Our unique MicroScanTM technology platform is development to meet customer's personalized customization needs.
Overview of High Throughput Compound Screening
High-throughput screening of compounds is a scientific experimental method especially suitable for the initial discovery of drugs and fields related to the fields of biology and chemistry.
- Libraries of Compound Screening
- DNA-encoded Chemical Libraries (DEL)
DNA-encoded chemical libraries (DEL) are a technology for synthesizing and screening collections of small molecules on an unprecedented scale. These compound collections consist of small molecules covalently attached to individual DNA sequences and contain human-readable information about the compound structure. - Synthetic Compound Libraries
The technique of attaching a library of synthetic compounds to the coat protein of bacteriophage particles is called synthetic compound library. The chemical structural identity is similar to peptides encoded in the phage genome and displayed on the phage surface by conventional phage display technology. This format allows very efficient screening of libraries of synthetic compounds as a pool. - Natural Compounds Libraries
Natural products are a treasure trove of pharmaceutical science. Natural products and their derivatives continue to play an important role in the discovery of new approved treatments, as they have done since the dawn of medical research. They have proven to be successful modulators of challenging targets, including various antimicrobial targets.
- High-content Compound Screening
High-content screening is an effective complement to traditional high-throughput screening. By using high-resolution fluorescent digital imaging systems, industry personnel conduct biological research and drug discovery. The detection range of this technology includes target activation, apoptosis, division index, cell viability, cell migration, cytotoxicity, cell cycle, etc. By obtaining detailed data on the multiple effects of active compounds on cells in the early stages of new drug research, researchers can significantly increase the rate of lead discovery and the success of later drug development.
Our Service
With the continuous development of human science, the methods of compound screening are also constantly innovating. CD BioSciences provides Bacteria-associated-compound screening service, which is based on the MicroScanTM technology platform. This technology platform provides screening of single compounds and screening of combined compounds. The platform's personalized customization service can also meet customers' different experimental needs, making customer's experiments easier and smoother.
- Prebiotics Screening Service
A preliminary screen for compounds with potential as prebiotics. - Synbiotics Screening Service
Develop a combination of single probiotic and prebiotic, or a combination of multiple probiotics and prebiotics. - Antibiotics Screening Service
Screening compounds that kill or inhibit bacteria as new antibiotics.
Features of Our Services
Unique Customization
Based on the screening requirements, the perform conditions design.
Fast Delivery
You are guaranteed to submit your results within your expected time.
Comprehensive Service
Professional pre-sales, in-sales and after-sales service to answer your questions in detail.